{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:03:12Z","timestamp":1787234592670,"version":"build-2736575974"},"reference-count":262,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>This Part 2 of a bipartite review commences with the delineation of a conceptual model outlining the fundamental role of injury-induced regulated cell death (RCD) in the release of DAMPs that drive innate immune responses involved in early inflammation-related allograft dysfunction and alloimmune-mediated allograft rejection. In relation to this topic, the focus is on the divergent role of donor and recipient dendritic cells (DCs), which become immunogenic in the presence of DAMPs to regulate alloimmunity, but in the absence of DAMPs acquire tolerogenic properties to promote allotolerance. With respect to this scenario, proposals are then made for leveraging RCD and DAMPs as biomarkers during normothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) of transplant organs from DCD donors, a strategy poised to significantly enhance current policies for assessing donor organ quality. The focus is then on the ambitious goal to target RCD and DAMPs therapeutically during NRP and NMP, aiming to profoundly suppress subsequently early allograft inflammation and alloimmunity in the recipient. This strategic approach seeks to prevent the activation of intragraft innate immune cells including DCs during donor organ reperfusion in the recipient, which is driven by ischemia\/reperfusion injury-induced DAMPs. In this context, available inhibitors of various types of RCD, as well as scavengers and inhibitors of DAMPs are highlighted for their promising therapeutic potential in NRP and NMP settings, building on their proven efficacy in other experimental disease models. If successful, this kind of therapeutic intervention should also be considered for application to organs from DBD donors. Finally, drawing on current global insights into the critical role of RCD and DAMPs in driving innate inflammatory and (allo)immune responses, targeting their inhibition and\/or prevention during normothermic perfusion of transplant organs from DCD donors - and potentially DBD donors - holds the transformative potential to not only alleviate transplant dysfunction and suppress allograft rejection but also foster allograft tolerance.<\/jats:p>","DOI":"10.3389\/frtra.2025.1575703","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:52:32Z","timestamp":1745499152000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies"],"prefix":"10.3389","volume":"4","author":[{"given":"Walter G.","family":"Land","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Linkermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00007890-199401001-00010","article-title":"The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants","volume":"57","author":"Land","year":"1994","journal-title":"Transplantation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0955-470X(02)00009-5","article-title":"Allograft injury mediated by reactive oxygen species: from conserved proteins of drosophila to acute and chronic rejection of human transplants. Part III: interaction of (oxidative) stress-induced heat shock proteins with toll-like receptor-bearing cells","volume":"17","author":"Land","year":"2003","journal-title":"Transplant Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1111\/ajt.13963","article-title":"Transplantation and damage-associated molecular patterns (DAMPs)","volume":"16","author":"Land","year":"2016","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00041.2016","article-title":"Origin and consequences of necroinflammation","volume":"98","author":"Sarhan","year":"2018","journal-title":"Physiol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.4049\/jimmunol.178.12.7503","article-title":"The innate immune system in allograft rejection and tolerance","volume":"178","author":"LaRosa","year":"2007","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.trre.2011.02.003","article-title":"Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells","volume":"26","author":"Land","year":"2012","journal-title":"Transplant Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4939-8938-6_12","article-title":"Immune tolerance and rejection in organ transplantation","volume":"1899","author":"Stolp","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41423-019-0216-2","article-title":"The innate immune response to allotransplants: mechanisms and therapeutic potentials","volume":"16","author":"Ochando","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3389\/fimmu.2019.02418","article-title":"Dendritic cells as sensors, mediators, and regulators of ischemic injury","volume":"10","author":"Dai","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41392-023-01377-9","article-title":"Activation of immune signals during organ transplantation","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","article-title":"Dendritic cells as gatekeepers of tolerance","volume":"39","author":"Waisman","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1073\/pnas.75.10.5132","article-title":"Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice","volume":"75","author":"Steinman","year":"1978","journal-title":"Proc Natl Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B19","first-page":"267","article-title":"Costimulation blockade in transplantation","volume-title":"Adv Exp Med Biol.","author":"Yeung","year":"2019"},{"key":"B20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2174\/1566523218666180214095956","article-title":"How do dendritic cells play the role in ischemia\/reperfusion triggered kidney allograft rejection","volume":"17","author":"Cai","year":"2018","journal-title":"Curr Gene Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"654540","DOI":"10.3389\/fimmu.2021.654540","article-title":"Dendritic cells: versatile players in renal transplantation","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1395945","DOI":"10.3389\/fimmu.2024.1395945","article-title":"Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants","volume":"15","author":"Ashraf","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000334245","article-title":"Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity","volume":"4","author":"Nace","year":"2012","journal-title":"J Innate Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","article-title":"Dying cells actively regulate adaptive immune responses","volume":"17","author":"Yatim","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/imr.13301","article-title":"Decoding immunogenic cell death from a dendritic cell perspective","volume":"321","author":"Janssens","year":"2024","journal-title":"Immunol Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2016.07.019","article-title":"Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in Thymus and periphery","volume":"45","author":"Ardouin","year":"2016","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4049\/jimmunol.1901121","article-title":"Natural and induced tolerogenic dendritic cells","volume":"204","author":"Iberg","year":"2020","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41577-024-01079-5","article-title":"Striking a balance: new perspectives on homeostatic dendritic cell maturation","volume":"25","author":"Bosteels","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.healun.2021.03.018","article-title":"Innate allorecognition in transplantation","volume":"40","author":"Abou-Daya","year":"2021","journal-title":"J Hear Lung Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.it.2016.09.003","article-title":"Antigen presentation in transplantation","volume":"37","author":"Alegre","year":"2016","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation","volume":"9","author":"Siu","year":"2018","journal-title":"Front Immunol"},{"key":"B36","first-page":"115","article-title":"MHC cross-dressing in antigen presentation","volume-title":"Adv Immunol.","author":"MacNabb","year":"2023"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100749","DOI":"10.1016\/j.bj.2024.100749","article-title":"Intercellular transfer of MHC molecules in T cell alloimmunity and allotransplantation","volume":"47","author":"Benichou","year":"2024","journal-title":"Biomed J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B39","first-page":"33","article-title":"The show and tell of cross-presentation","volume-title":"Adv Immunol.","author":"Blander","year":"2023"},{"key":"B40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40472-016-0115-8","article-title":"What is direct allorecognition?","volume":"3","author":"Boardman","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/tri.13504","article-title":"Tolerogenic dendritic cells in organ transplantation","volume":"33","author":"Ochando","year":"2020","journal-title":"Transpl Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4049\/jimmunol.2100932","article-title":"Variegated outcomes of T cell activation by dendritic cells in the steady state","volume":"208","author":"Bourque","year":"2022","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science (80-)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.trre.2011.07.001","article-title":"Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences","volume":"26","author":"Land","year":"2012","journal-title":"Transplant Rev"},{"key":"B46","first-page":"46","article-title":"How evolution tells us to induce allotolerance","volume":"13","author":"Land","year":"2015","journal-title":"Exp Clin Transpl"},{"key":"B47","doi-asserted-by":"publisher","first-page":"864633","DOI":"10.3389\/fimmu.2022.864633","article-title":"Autoimmunity: are we asking the right question?","volume":"13","author":"Matzinger","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.trre.2019.05.001","article-title":"Regulatory dendritic cells for human organ transplantation","volume":"33","author":"Thomson","year":"2019","journal-title":"Transplant Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"582658","DOI":"10.3389\/fimmu.2020.582658","article-title":"Manipulation of regulatory dendritic cells for induction transplantation tolerance","volume":"11","author":"Que","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/ajt.15323","article-title":"Outstanding questions in transplantation: b cells, alloantibodies, and humoral rejection","volume":"19","author":"Chong","year":"2019","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41581-022-00600-0","article-title":"Activation and regulation of alloreactive T cell immunity in solid organ transplantation","volume":"18","author":"Duneton","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/tri.14121","article-title":"A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation","volume":"34","author":"De Beule","year":"2021","journal-title":"Transpl Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1450","DOI":"10.1097\/TXD.0000000000001450","article-title":"Normothermic regional perfusion can improve both utilization and outcomes in DCD liver, kidney, and pancreas transplantation","volume":"9","author":"Bekki","year":"2023","journal-title":"Transplant Direct"},{"key":"B55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1432-2277.2000.tb01086.x","article-title":"Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors","volume":"13","author":"Valero","year":"2000","journal-title":"Transpl Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2018.12.013","article-title":"Normothermic regional perfusion vs. Super-rapid recovery in controlled donation after circulatory death liver transplantation","volume":"70","author":"Hessheimer","year":"2019","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/tri.13951","article-title":"Consensus statement on normothermic regional perfusion in donation after circulatory death: report from the European society for organ transplantation\u2019s transplant learning journey","volume":"34","author":"Jochmans","year":"2021","journal-title":"Transpl Int"},{"key":"B58","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.jceh.2023.101309","article-title":"Current techniques and indications for machine perfusion and regional perfusion in deceased donor liver transplantation","volume":"14","author":"Watson","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/jcm12010235","article-title":"A meta-analysis and systematic review of normothermic and hypothermic machine perfusion in liver transplantation","volume":"12","author":"Mugaanyi","year":"2023","journal-title":"J Clin Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jhep.2018.09.019","article-title":"Ex situ machine perfusion strategies in liver transplantation","volume":"70","author":"de Meijer","year":"2019","journal-title":"J Hepatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/S0140-6736(15)60038-1","article-title":"Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series","volume":"385","author":"Dhital","year":"2015","journal-title":"Lancet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/S0140-6736(12)61344-0","article-title":"Normothermic perfusion of donor lungs for preservation and assessment with the organ care system lung before bilateral transplantation: a pilot study of 12 patients","volume":"380","author":"Warnecke","year":"2012","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1111\/ajt.13906","article-title":"Successful transplantation of human kidneys deemed untransplantable but resuscitated by ex vivo normothermic machine perfusion","volume":"16","author":"Hosgood","year":"2016","journal-title":"Am J Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.3390\/jcm12113718","article-title":"Normothermic ex vivo machine perfusion for liver transplantation: a systematic review of progress in humans","volume":"12","author":"Risbey","year":"2023","journal-title":"J Clin Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MOT.0000000000001003","article-title":"Normothermic machine perfusion of kidneys: current strategies and future perspectives","volume":"27","author":"Messner","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3389\/ti.2023.10936","article-title":"Normothermic ex vivo machine perfusion of discarded human pancreas allografts: a feasibility study","volume":"36","author":"Parmentier","year":"2023","journal-title":"Transpl Int"},{"key":"B68","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/SLA.0000000000006462","article-title":"Revolutionizing liver transplantation:transitioning to an elective procedure via ex situ normothermic machine perfusion - A benefit analysis","volume":"280","author":"Li","year":"2024","journal-title":"Ann Surg"},{"key":"B69","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/TP.0000000000005132","article-title":"Normothermic machine perfusion and normothermic regional perfusion of DCD kidneys before transplantation: a systematic review","volume":"109","author":"Nulend","year":"2025","journal-title":"Transplantation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/SLA.0000000000006291","article-title":"Impact of back-to-base normothermic machine perfusion on complications and costs","volume":"280","author":"Wehrle","year":"2024","journal-title":"Ann Surg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/ajt.16307","article-title":"Normothermic kidney perfusion: an overview of protocols and strategies","volume":"21","author":"Elliott","year":"2021","journal-title":"Am J Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.3390\/jcm12123871","article-title":"Outcomes of kidney perfusion techniques in transplantation from deceased donors: a systematic review and meta-analysis","volume":"12","author":"Ghoneima","year":"2023","journal-title":"J Clin Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41591-023-02376-7","article-title":"Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial","volume":"29","author":"Hosgood","year":"2023","journal-title":"Nat Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"10236","DOI":"10.3389\/ti.2022.10236","article-title":"Perfusate composition and duration of ex-vivo normothermic perfusion in kidney transplantation: a systematic review","volume":"35","author":"Fard","year":"2022","journal-title":"Transpl Int"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41587-022-01354-7","article-title":"Transplantation of a human liver following 3 days of ex situ normothermic preservation","volume":"40","author":"Clavien","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1097\/01.TP.0000119206.63326.56","article-title":"Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion","volume":"77","author":"Reddy","year":"2004","journal-title":"Transplantation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41467-020-16251-3","article-title":"Transplantation of discarded livers following viability testing with normothermic machine perfusion","volume":"11","author":"Mergental","year":"2020","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1728","DOI":"10.1097\/TXD.0000000000001728","article-title":"Dynamics of ischemia\/reperfusion injury markers during normothermic liver machine perfusion","volume":"10","author":"Caballero-Marcos","year":"2024","journal-title":"Transplant Direct"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jhep.2014.07.023","article-title":"Warm vs. cold perfusion techniques to rescue rodent liver grafts","volume":"61","author":"Schlegel","year":"2014","journal-title":"J Hepatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trre.2011.05.001","article-title":"Emerging role of innate immunity in organ transplantation part I: evolution of innate immunity and oxidative allograft injury","volume":"26","author":"Land","year":"2012","journal-title":"Transplant Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5500\/wjt.v9.i1.14","article-title":"Machine perfusion of the liver: which is the best technique to mitigate ischaemia-reperfusion injury?","volume":"9","author":"Boteon","year":"2019","journal-title":"World J Transplant"},{"key":"B82","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.healun.2017.06.005","article-title":"Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation","volume":"37","author":"Hashimoto","year":"2018","journal-title":"J Hear Lung Transplant"},{"key":"B83","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/Lt.25429","article-title":"Damage-associated molecular patterns induce inflammatory injury during machine preservation of the liver: potential targets to enhance a promising technology","volume":"25","author":"Scheuermann","year":"2019","journal-title":"Liver Transplant"},{"key":"B84","doi-asserted-by":"publisher","first-page":"849742","DOI":"10.3389\/fimmu.2022.849742","article-title":"The effects of free heme on functional and molecular changes during ex vivo normothermic machine perfusion of human kidneys","volume":"13","author":"Hosgood","year":"2022","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"28","DOI":"10.57603\/EJT-006","article-title":"Advances in normothermic machine perfusion of the kidney: evidence for clinical practice and underlying mechanistic actions","volume":"1","author":"Hosgood","year":"2023","journal-title":"EJT"},{"key":"B86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40291-020-00460-z","article-title":"Use of DAMPs and SAMPs as therapeutic targets or therapeutics: a note of caution","volume":"24","author":"Land","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-023-37674-8","article-title":"Immune cell dynamics deconvoluted by single-cell RNA sequencing in normothermic machine perfusion of the liver","volume":"14","author":"Hautz","year":"2023","journal-title":"Nat Commun"},{"key":"B88","first-page":"520","article-title":"Injury to allografts: innate immune pathways to acute and chronic rejection","volume":"16","author":"Land","year":"2005","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B89","first-page":"575","article-title":"Innate alloimmunity: history and current knowledge","volume":"5","author":"Land","year":"2007","journal-title":"Ex Clin Transpl"},{"key":"B90","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/ajt.14583","article-title":"The first case of ischemia-free organ transplantation in humans: a proof of concept","volume":"18","author":"He","year":"2018","journal-title":"Am J Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.lanwpc.2021.100260","article-title":"Ischaemia-free liver transplantation in humans: a first-in-human trial","volume":"16","author":"Guo","year":"2021","journal-title":"Lancet Reg Health West Pacific"},{"key":"B92","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2023.04.010","article-title":"A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease","volume":"79","author":"Guo","year":"2023","journal-title":"J Hepatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hbpd.2024.10.002","article-title":"Research progress of ischemia-free liver transplantation","volume":"24","author":"Zhang","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/aor.14622","article-title":"Viability assessment of livers donated after circulatory determination of death during normothermic regional perfusion","volume":"47","author":"Steinberg","year":"2023","journal-title":"Artif Organs"},{"key":"B95","doi-asserted-by":"publisher","first-page":"466","DOI":"10.14218\/JCTH.2022.00130","article-title":"Comprehensive approach to assessment of liver viability during normothermic machine perfusion","volume":"11","author":"Li","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13167-024-00371-7","article-title":"Liver function maximum capacity test during normothermic regional perfusion predicts graft function after transplantation","volume":"15","author":"Schurink","year":"2024","journal-title":"EPMA J"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.transproceed.2021.05.013","article-title":"Clinical utility and evolution of donor serum lactate during normothermic regional perfusion in uncontrolled donation after circulatory death","volume":"53","author":"Rodr\u00edguez-Villar","year":"2021","journal-title":"Transplant Proc"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/TP.0000000000002500","article-title":"Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers","volume":"103","author":"Matton","year":"2019","journal-title":"Transplantation"},{"key":"B99","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s40472-022-00378-x","article-title":"Normothermic machine perfusion in renal transplantation","volume":"9","author":"Norton","year":"2022","journal-title":"Curr Transplant Reports"},{"key":"B100","doi-asserted-by":"publisher","first-page":"801098","DOI":"10.3389\/fmed.2021.801098","article-title":"Hemodynamics and metabolic parameters in normothermic kidney preservation are linked with donor factors, perfusate cells, and cytokines","volume":"8","author":"Weissenbacher","year":"2022","journal-title":"Front Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00018-016-2192-3","article-title":"Biomarkers for the detection of necroptosis","volume":"73","author":"He","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"84066","DOI":"10.18632\/oncotarget.21099","article-title":"Necroptosis regulated proteins expression is an early prognostic biomarker in patient with sepsis: a prospective observational study","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1983421","article-title":"Elevated serum levels of mixed lineage kinase domain-like protein predict survival of patients during intensive care unit treatment","volume":"2018","author":"Vucur","year":"2018","journal-title":"Dis Markers"},{"key":"B104","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jncc.2022.08.007","article-title":"Methodological advances in necroptosis research: from challenges to solutions","volume":"2","author":"Wan","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"B105","doi-asserted-by":"publisher","first-page":"117196","DOI":"10.1016\/j.biopha.2024.117196","article-title":"Recognition of necroptosis: from molecular mechanisms to detection methods","volume":"178","author":"Zhu","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B106","doi-asserted-by":"publisher","first-page":"398","DOI":"10.20892\/j.issn.2095-3941.2021.0504","article-title":"Methods for monitoring cancer cell pyroptosis","volume":"19","author":"Wang","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2312534","DOI":"10.1080\/0886022X.2024.2312534","article-title":"The serum levels of gasdermin D in uremic patients and its relationship with the prognosis: a prospective observational cohort study","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren Fail"},{"key":"B108","doi-asserted-by":"publisher","first-page":"998470","DOI":"10.3389\/fimmu.2022.998470","article-title":"Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1478395","DOI":"10.3389\/fimmu.2024.1478395","article-title":"SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1486209","DOI":"10.3389\/fimmu.2024.1486209","article-title":"Integration of bulk\/scRNA-seq and multiple machine learning algorithms identifies PIM1 as a biomarker associated with cuproptosis and ferroptosis in abdominal aortic aneurysm","volume":"15","author":"Han","year":"2024","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e202300379","DOI":"10.1002\/anie.202300379","article-title":"Ferroptosis detection: from approaches to applications","volume":"62","author":"Zeng","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"B112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2016.05.029","article-title":"NETosis markers: quest for specific, objective, and quantitative markers","volume":"459","author":"Masuda","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2022.02.025","article-title":"Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state","volume":"213","author":"Mo\u0142ek","year":"2022","journal-title":"Thromb Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/SHK.0000000000002460","article-title":"NINJ1: a novel sepsis severity and mortality biomarker","volume":"63","author":"Wu","year":"2025","journal-title":"Shock"},{"key":"B115","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00431-017-2907-y","article-title":"Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury","volume":"176","author":"Westhoff","year":"2017","journal-title":"Eur J Pediatr"},{"key":"B116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mehy.2016.12.008","article-title":"Could \u201ccalprotectin\u201d and \u201cendocan\u201d serve as \u201ctroponin of nephrologists\u201d?","volume":"99","author":"Azimi","year":"2017","journal-title":"Med Hypotheses"},{"key":"B117","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000475883","article-title":"Urinary mitochondrial DNA level as a biomarker of acute kidney injury severity","volume":"3","author":"Ho","year":"2017","journal-title":"Kidney Dis"},{"key":"B118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/SHK.0000000000000830","article-title":"Urinary mitochondrial DNA levels identify acute kidney injury in surgical critical illness patients","volume":"48","author":"Hu","year":"2017","journal-title":"Shock"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ki.2015.240","article-title":"Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury","volume":"88","author":"Whitaker","year":"2015","journal-title":"Kidney Int"},{"key":"B120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0039-1679919","article-title":"Acetaminophen hepatotoxicity","volume":"39","author":"Ramachandran","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S2468-1253(17)30266-2","article-title":"Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies","volume":"3","author":"Dear","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14740338.2016.1160057","article-title":"Recent advances in biomarkers and therapeutic interventions for hepatic drug safety\u2014false dawn or new horizon?","volume":"15","author":"Clarke","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/hep.30617","article-title":"Biomarkers of macrophage activation and immune danger signals predict clinical outcomes in alcoholic hepatitis","volume":"70","author":"Saha","year":"2019","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1164\/rccm.200402-188OC","article-title":"Contributions of high mobility group box protein in experimental and clinical acute lung injury","volume":"170","author":"Ueno","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/SHK.0b013e318157eddd","article-title":"Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia","volume":"29","author":"van Zoelen","year":"2008","journal-title":"Shock"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/804654","article-title":"Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome","volume":"2014","author":"Tseng","year":"2014","journal-title":"Dis Markers"},{"key":"B128","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12931-017-0651-5","article-title":"Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome","volume":"18","author":"Lv","year":"2017","journal-title":"Respir Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/TA.0000000000001269","article-title":"Mitochondrial DNA damage associated molecular patterns in ventilator-associated pneumonia: prevention and reversal by intratracheal DNase I","volume":"82","author":"Simmons","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.healun.2022.05.013","article-title":"Cell death and ischemia-reperfusion injury in lung transplantation","volume":"41","author":"Capuzzimati","year":"2022","journal-title":"J Hear Lung Transplant"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e1265","DOI":"10.1097\/TXD.0000000000001265","article-title":"Mitochondrial damage-associated molecular patterns as potential biomarkers in DCD heart transplantation: lessons from myocardial infarction and cardiac arrest","volume":"8","author":"Longnus","year":"2021","journal-title":"Transplant Direct"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e27122","DOI":"10.1016\/j.heliyon.2024.e27122","article-title":"Mitochondrial DNA levels in perfusate and bile during ex vivo normothermic machine correspond with donor liver quality","volume":"10","author":"Westhaver","year":"2024","journal-title":"Heliyon"},{"key":"B133","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transpl Int"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/jcm9041046","article-title":"Normothermic machine perfusion (NMP) of the liver as a platform for therapeutic interventions during ex-vivo liver preservation: a review","volume":"9","author":"Dengu","year":"2020","journal-title":"J Clin Med"},{"key":"B135","doi-asserted-by":"publisher","first-page":"850271","DOI":"10.3389\/fimmu.2022.850271","article-title":"Kidney normothermic machine perfusion can be used as a preservation technique and a model of reperfusion to deliver novel therapies and assess inflammation and immune activation","volume":"13","author":"Mellati","year":"2022","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ajt.2024.01.001","article-title":"Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion","volume":"24","author":"Ogurlu","year":"2024","journal-title":"Am J Transplant"},{"key":"B137","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000542290","article-title":"Current basic research in normothermic machine perfusion","volume":"65","author":"Hosgood","year":"2024","journal-title":"Eur Surg Res"},{"key":"B138","first-page":"406","article-title":"Immunosuppressive strategies in organ transplantation in the light of innate immunity","volume":"4","author":"Land","year":"2006","journal-title":"Exp Clin Transpl"},{"key":"B139","first-page":"760","volume-title":"Innate Alloimmunity: Part 2: Innate Immunity and Allograft Rejection","author":"Land","year":"2011"},{"key":"B140","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1038\/s41598-020-63687-0","article-title":"Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform","volume":"10","author":"Hameed","year":"2020","journal-title":"Sci Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1404668","DOI":"10.3389\/fimmu.2024.1404668","article-title":"Heart immunoengineering by lentiviral vector-mediated genetic modification during normothermic ex vivo perfusion","volume":"15","author":"Schmalkuche","year":"2024","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1111\/ajt.17161","article-title":"The current status of stem cell-based therapies during ex vivo graft perfusion: an integrated review of four organs","volume":"22","author":"Luijmes","year":"2022","journal-title":"Am J Transplant"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-023-06191-5","article-title":"Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury","volume":"618","author":"Kayagaki","year":"2023","journal-title":"Nature"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41418-024-01350-1","article-title":"Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases","volume":"31","author":"Maremonti","year":"2024","journal-title":"Cell Death Differ"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1587922","article-title":"Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","article-title":"Ferroptotic cell death and TLR4\/trif signaling initiate neutrophil recruitment after heart transplantation","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e174354","DOI":"10.1172\/jci.insight.174354","article-title":"Cold stress\u2013induced ferroptosis in liver sinusoidal endothelial cells determines liver transplant injury and outcomes","volume":"9","author":"Kojima","year":"2024","journal-title":"JCI Insight"},{"key":"B148","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","article-title":"Synchronized renal tubular cell death involves ferroptosis","volume":"111","author":"Linkermann","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B149","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tips.2023.08.012","article-title":"Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors","volume":"44","author":"Scarpellini","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1407335","DOI":"10.3389\/fphar.2024.1407335","article-title":"Ferroptosis inhibitors: past, present and future","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e2300320120","DOI":"10.1073\/pnas.2300320120","article-title":"vPIF-1 is an insulin-like antiferroptotic viral peptide","volume":"120","author":"Belavgeni","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"B152","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13054-016-1504-1","article-title":"N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial","volume":"20","author":"Fraga","year":"2016","journal-title":"Crit Care"},{"key":"B153","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1681\/ASN.2019060570","article-title":"Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers","volume":"31","author":"Mishima","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","article-title":"7-Dehydrocholesterol Is an endogenous suppressor of ferroptosis","volume":"626","author":"Freitas","year":"2024","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3892\/ijmm.2019.4244","article-title":"RIP1\/RIP3-regulated necroptosis as a target for multifaceted disease therapy (review)","volume":"44","author":"Liu","year":"2019","journal-title":"Int J Mol Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol Res"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.jmedchem.2c01621","article-title":"From (tool)Bench to bedside: the potential of necroptosis inhibitors","volume":"66","author":"Gardner","year":"2023","journal-title":"J Med Chem"},{"key":"B159","doi-asserted-by":"publisher","first-page":"116123","DOI":"10.1016\/j.ejmech.2024.116123","article-title":"RIPK1 inhibitors: a key to unlocking the potential of necroptosis in drug development","volume":"265","author":"Bai","year":"2024","journal-title":"Eur J Med Chem"},{"key":"B160","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10495-023-01905-6","article-title":"Necroptosis inhibitors: mechanisms of action and therapeutic potential","volume":"29","author":"Zhou","year":"2024","journal-title":"Apoptosis"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1038\/s41467-021-24712-6","article-title":"Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury","volume":"12","author":"Tonnus","year":"2021","journal-title":"Nat Commun"},{"key":"B162","doi-asserted-by":"publisher","first-page":"16115","DOI":"10.3390\/ijms232416115","article-title":"Molecular characteristics of cell pyroptosis and its inhibitors: a review of activation, regulation, and inhibitors","volume":"23","author":"Wei","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B164","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B165","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-024-01801-8","article-title":"The gasdermin family: emerging therapeutic targets in diseases","volume":"9","author":"Zhu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B166","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","article-title":"Control of cell death in health and disease","volume":"19","author":"Kayagaki","year":"2024","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"B167","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/cts.13576","article-title":"First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers","volume":"16","author":"Tang","year":"2023","journal-title":"Clin Transl Sci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e13789","DOI":"10.1111\/cts.13789","article-title":"First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor","volume":"17","author":"Gatlik","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat Immunol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e0259061","DOI":"10.1371\/journal.pone.0259061","article-title":"Disulfiram use is associated with lower risk of COVID-19: a retrospective cohort study","volume":"16","author":"Fillmore","year":"2021","journal-title":"PLoS One"},{"key":"B173","doi-asserted-by":"publisher","first-page":"14396","DOI":"10.3390\/ijms232214396","article-title":"Emerging role of NLRP3 inflammasome and pyroptosis in liver transplantation","volume":"23","author":"Lucas-Ruiz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/cells11213420","article-title":"Correlation between neutrophil extracellular traps (NETs) expression and primary graft dysfunction following human lung transplantation","volume":"11","author":"Bonneau","year":"2022","journal-title":"Cells"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e167012","DOI":"10.1172\/JCI167012","article-title":"Avoid being trapped by your liver: ischemia-reperfusion injury in liver transplant triggers S1P-mediated NETosis","volume":"133","author":"Scozzi","year":"2023","journal-title":"J Clin Invest"},{"key":"B176","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1002\/mco2.162","article-title":"Molecular mechanisms and therapeutic target of NETosis in diseases","volume":"3","author":"Huang","year":"2022","journal-title":"MedComm"},{"key":"B178","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/life14010065","article-title":"Hemoadsorption in organ preservation and transplantation: a narrative review","volume":"14","author":"Garc\u00eda-Villegas","year":"2023","journal-title":"Life"},{"key":"B179","volume-title":"Damage Associated Molecular Pattern (DAMP) Removal During Liver Normothermic Machine Perfusion Facilitates Organ Rescue and Reconditioning During Preservation","author":"Dengu","year":"2024"},{"key":"B180","doi-asserted-by":"publisher","first-page":"104419","DOI":"10.1016\/j.ebiom.2022.104419","article-title":"Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation","volume":"87","author":"Lucas-Ruiz","year":"2023","journal-title":"eBioMedicine"},{"key":"B181","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.3390\/ijms22168882","article-title":"Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification","volume":"22","author":"Moriyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B182","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1002\/jcp.30125","article-title":"HMGB1 As a therapeutic target in disease","volume":"236","author":"Xue","year":"2021","journal-title":"J Cell Physiol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1272\/jnms.JNMS.2018_85-22","article-title":"Plasma adsorption membranes are able to efficiently remove high mobility group box-1 (HMGB-1)","volume":"85","author":"Onohara","year":"2018","journal-title":"J Nippon Med Sch"},{"key":"B184","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13054-023-04382-0","article-title":"Targeting circulating high mobility group box-1 and histones by extracorporeal blood purification as an immunomodulation strategy against critical illnesses","volume":"27","author":"Li","year":"2023","journal-title":"Crit Care"},{"key":"B185","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J"},{"key":"B186","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.amjsurg.2015.06.025","article-title":"Anti\u2013high mobility group box 1 monoclonal antibody improves ischemia\/reperfusion injury and mode of liver regeneration after partial hepatectomy","volume":"211","author":"Sugihara","year":"2016","journal-title":"Am J Surg"},{"key":"B187","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbrc.2021.08.015","article-title":"Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice","volume":"573","author":"Nakata","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hep.28736","article-title":"A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice","volume":"64","author":"Lundb\u00e4ck","year":"2016","journal-title":"Hepatology"},{"key":"B189","doi-asserted-by":"publisher","first-page":"113912","DOI":"10.1016\/j.yexcr.2024.113912","article-title":"Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway","volume":"435","author":"Zhu","year":"2024","journal-title":"Exp Cell Res"},{"key":"B190","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.tips.2023.10.001","article-title":"Potential therapeutic targets for trauma management","volume":"44","author":"Li","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/jcp.27110","article-title":"Heat shock protein 70: a promising therapeutic target for myocardial ischemia\u2013reperfusion injury","volume":"234","author":"Song","year":"2019","journal-title":"J Cell Physiol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"15063","DOI":"10.3390\/ijms232315063","article-title":"Onset of adverse abdominal events due to intestinal ischemia-reperfusion injury after aortic cross-clamping is associated with elevated HSP70 Serum levels in the early postoperative phase","volume":"23","author":"Doukas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B193","doi-asserted-by":"publisher","first-page":"eRB6181","DOI":"10.31744\/einstein_journal\/2022RB6181","article-title":"What is the role of heat shock protein in abdominal organ transplantation?","volume":"20","author":"Calil","year":"2022","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"B194","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1002\/mco2.161","article-title":"Heat shock proteins: biological functions, pathological roles, and therapeutic opportunities","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e15006","DOI":"10.1111\/ctr.15006","article-title":"S100a8\/A9 as a prognostic biomarker in lung transplantation","volume":"37","author":"Nakata","year":"2023","journal-title":"Clin Transplant"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1394137","DOI":"10.3389\/fcvm.2024.1394137","article-title":"S100a8\/A9 proteins: critical regulators of inflammation in cardiovascular diseases","volume":"11","author":"Sun","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B197","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/bioengineering9110673","article-title":"Functional blockage of S100A8\/A9 ameliorates ischemia\u2013reperfusion injury in the lung","volume":"9","author":"Nakata","year":"2022","journal-title":"Bioengineering"},{"key":"B198","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.intimp.2013.12.008","article-title":"The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effects","volume":"18","author":"Deronic","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1134\/S000629791510020X","article-title":"Level of blood cell-free circulating mitochondrial DNA as a novel biomarker of acute myocardial ischemia","volume":"80","author":"Sudakov","year":"2015","journal-title":"Biochem"},{"key":"B201","doi-asserted-by":"publisher","first-page":"e14469","DOI":"10.1111\/ctr.14469","article-title":"Mitochondrial DNA may act as a biomarker to predict donor-kidney quality","volume":"35","author":"Hao","year":"2021","journal-title":"Clin Transplant"},{"key":"B202","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nephro.2020.10.003","article-title":"The role of donor-derived cell-free DNA in the detection of renal allograft injury","volume":"17","author":"Zhou","year":"2021","journal-title":"N\u00e9phrol Th\u00e9r"},{"key":"B203","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1164\/rccm.202306-1064OC","article-title":"Cell-free DNA maps tissue injury and correlates with disease severity in lung transplant candidates","volume":"209","author":"Balasubramanian","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6235747","article-title":"Mitochondrial DNA is a vital driving force in ischemia-reperfusion injury in cardiovascular diseases","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2174\/1389201020666190102150610","article-title":"Extracellular RNA, a potential drug target for alleviating atherosclerosis, ischemia\/reperfusion injury and organ transplantation","volume":"19","author":"Kluever","year":"2019","journal-title":"Curr Pharm Biotechnol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"166790","DOI":"10.1016\/j.bbadis.2023.166790","article-title":"Extracellular RNAs\/TLR3 signaling contributes to acute intestinal injury induced by intestinal ischemia reperfusion in mice","volume":"1869","author":"Lei","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B207","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10557-020-06946-6","article-title":"The role of extracellular DNA and histones in ischaemia-reperfusion injury of the myocardium","volume":"34","author":"Shah","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"B208","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3389\/fimmu.2018.00891","article-title":"Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage","volume":"9","author":"Aswani","year":"2018","journal-title":"Front Immunol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1038\/s41598-023-30421-5","article-title":"Early DNase-I therapy delays secondary brain damage after traumatic brain injury in adult mice","volume":"13","author":"Kr\u00e4mer","year":"2023","journal-title":"Sci Rep"},{"key":"B210","doi-asserted-by":"publisher","first-page":"17788","DOI":"10.1038\/s41598-018-36198-2","article-title":"DNase-1 treatment exerts protective effects in a rat model of intestinal ischemia-reperfusion injury","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"B211","doi-asserted-by":"publisher","first-page":"e2812","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1438984","DOI":"10.3389\/fimmu.2024.1438984","article-title":"Emerging therapeutic strategies targeting extracellular histones for critical and inflammatory diseases: an updated narrative review","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/jcm9051421","article-title":"Effects of circulating HMGB-1 and histones on cardiomyocytes\u2013hemadsorption of these DAMPs as therapeutic strategy after multiple trauma","volume":"9","author":"Weber","year":"2020","journal-title":"J Clin Med"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/ijms23031823","article-title":"Heparin-functionalized adsorbents eliminate central effectors of immunothrombosis, including platelet factor 4, high-mobility group box 1 protein and histones","volume":"23","author":"Ebeyer-Masotta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2014.00061","article-title":"Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes","volume":"5","author":"Chiabrando","year":"2014","journal-title":"Front Pharmacol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fimmu.2020.01323","article-title":"Pro-inflammatory actions of heme and other hemoglobin-derived DAMPs","volume":"11","author":"Bozza","year":"2020","journal-title":"Front Immunol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1263384","DOI":"10.3389\/fimmu.2023.1263384","article-title":"Editorial: heme proteins: key players in the regulation of immune responses","volume":"14","author":"Volpi","year":"2023","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/biom13030575","article-title":"Heme scavenging and delivery: the role of human serum albumin","volume":"13","author":"De Simone","year":"2023","journal-title":"Biomolecules"},{"key":"B219","doi-asserted-by":"publisher","first-page":"2219591","DOI":"10.1080\/2162402X.2023.2219591","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in oncology","volume":"12","author":"Sprooten","year":"2023","journal-title":"Oncoimmunology"},{"key":"B220","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J Exp Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.4049\/jimmunol.165.3.1599","article-title":"Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate","volume":"165","author":"Kodaira","year":"2000","journal-title":"J Immunol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00262-019-02400-1","article-title":"Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy","volume":"68","author":"Fyrstenberg Laursen","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B224","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2013.00138","article-title":"The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity","volume":"4","author":"Gallo","year":"2013","journal-title":"Front Immunol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"13994","DOI":"10.1073\/pnas.1510760112","article-title":"Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation","volume":"112","author":"Hu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B226","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.4049\/jimmunol.1302244","article-title":"Differential ability of surface and endosomal TLRs to induce CD8T cell responses in vivo","volume":"192","author":"Mandraju","year":"2014","journal-title":"J Immunol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41392-024-01881-6","article-title":"DNA of neutrophil extracellular traps promote NF-\u03baB-dependent autoimmunity via cGAS\/TLR9 in chronic obstructive pulmonary disease","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B228","doi-asserted-by":"publisher","first-page":"e1102","DOI":"10.1038\/cddis.2014.70","article-title":"Extracellular ATP drives systemic inflammation, tissue damage and mortality","volume":"5","author":"Cauwels","year":"2014","journal-title":"Cell Death Dis"},{"key":"B229","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/antib10030031","article-title":"Epitope mapping of monoclonal antibodies to calreticulin reveals that charged amino acids are essential for antibody binding","volume":"10","author":"Bergmann","year":"2021","journal-title":"Antibodies"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/13543784.2020.1797677","article-title":"Type I interferon antagonists in clinical development for lupus","volume":"29","author":"Paredes","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1177\/0961203320959702","article-title":"Biologics targeting type I interferons in SLE: a meta-analysis and systematic review of randomised controlled trials","volume":"29","author":"Koh","year":"2020","journal-title":"Lupus"},{"key":"B232","first-page":"7","volume-title":"Tumor Necrosis Factor InhibitorsStatPearls","author":"Gerriets","year":"2023"},{"key":"B233","first-page":"135","article-title":"CD40-CD40l costimulation blockade induced the tolerogenic dendritic cells in mouse cardiac transplant","volume":"95","author":"Jiang","year":"2010","journal-title":"Int Surg"},{"key":"B234","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cll.2018.10.009","article-title":"The role of costimulatory pathways in transplant tolerance","volume":"39","author":"Uehara","year":"2019","journal-title":"Clin Lab Med"},{"key":"B235","doi-asserted-by":"publisher","first-page":"537079","DOI":"10.3389\/fimmu.2021.537079","article-title":"Recent advances in costimulatory blockade to induce immune tolerance in liver transplantation","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MOT.0000000000000656","article-title":"The past, present, and future of costimulation blockade in organ transplantation","volume":"24","author":"Schroder","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"B237","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.ekir.2023.08.037","article-title":"Costimulatory blockade and solid organ transplantation: the past, present, and future","volume":"8","author":"Kitchens","year":"2023","journal-title":"Kidney Int Reports"},{"key":"B238","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/FTD.0000000000001275","article-title":"New developments and therapeutic drug monitoring options in costimulatory blockade in solid organ transplantation: a systematic critical review","volume":"47","author":"de Graav","year":"2025","journal-title":"Ther Drug Monit"},{"key":"B239","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"B240","doi-asserted-by":"publisher","first-page":"189","DOI":"10.37349\/ei.2024.00136","article-title":"Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies","volume":"4","author":"El Jamal","year":"2024","journal-title":"Explor Immunol"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1097\/TP.0000000000004985","article-title":"Efficacy and safety of bleselumab in preventing the recurrence of primary focal segmental glomerulosclerosis in kidney transplant recipients: a phase 2a, randomized, multicenter study","volume":"108","author":"Shoji","year":"2024","journal-title":"Transplantation"},{"key":"B242","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0140-6736(24)01211-X","article-title":"Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sj\u00f6gren\u2019s disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study","volume":"404","author":"Fisher","year":"2024","journal-title":"Lancet"},{"key":"B243","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/art.40479","article-title":"Brief report: a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis","volume":"70","author":"Cheng","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bjd\/ljad240","article-title":"Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial","volume":"189","author":"Weidinger","year":"2023","journal-title":"Br J Dermatol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","article-title":"The therapeutic potential of targeting regulated non-apoptotic cell death","volume":"22","author":"Hadian","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/TP.0000000000002239","article-title":"State of the art: role of the dendritic cell in induction of allograft tolerance","volume":"102","author":"Rosen","year":"2018","journal-title":"Transplantation"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/TP.0000000000002242","article-title":"Contemporary strategies and barriers to transplantation tolerance","volume":"102","author":"Ezekian","year":"2018","journal-title":"Transplantation"},{"key":"B248","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00134-018-5464-6","article-title":"Hemoadsorption with CytoSorb\u00ae","volume":"45","author":"Poli","year":"2019","journal-title":"Intensive Care Med"},{"key":"B249","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41587-019-0015-4","article-title":"Antigen-specific therapeutic approaches for autoimmunity","volume":"37","author":"Serra","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"654701","DOI":"10.3389\/fimmu.2021.654701","article-title":"Potential for antigen-specific tolerizing immunotherapy in systematic lupus erythematosus","volume":"12","author":"Robinson","year":"2021","journal-title":"Front Immunol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B252","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science (80-)"},{"key":"B253","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00393-023-01453-z","article-title":"Why the regeneration of immunological tolerance by vaccination is difficult","volume":"83","author":"Radbruch","year":"2024","journal-title":"Z Rheumatol"},{"key":"B254","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1073\/pnas.0800149105","article-title":"Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression","volume":"105","author":"Verginis","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"B255","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B256","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/TP.0000000000003303","article-title":"The role of SLAs in xenotransplantation","volume":"105","author":"Ladowski","year":"2021","journal-title":"Transplantation"},{"key":"B257","doi-asserted-by":"publisher","first-page":"844315","DOI":"10.3389\/fimmu.2021.844315","article-title":"Editorial: DAMPs across the tree of life","volume":"12","author":"Seong","year":"2022","journal-title":"Front Immunol"},{"key":"B258","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2307\/4444260","article-title":"Nothing in biology makes sense except in the light of evolution","volume":"35","author":"Dobzhansky","year":"1973","journal-title":"Am Biol Teach"},{"key":"B259","doi-asserted-by":"publisher","first-page":"e21550","DOI":"10.1096\/fj.202000856R","article-title":"Evolutionary and functional analyses demonstrate conserved ferroptosis protection by Arabidopsis GPXs in mammalian cells","volume":"35","author":"Song","year":"2021","journal-title":"FASEB J"},{"key":"B260","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00002.2021","article-title":"The evolution of regulated cell death pathways in animals and their evasion by pathogens","volume":"102","author":"Tummers","year":"2022","journal-title":"Physiol Rev"},{"key":"B261","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","article-title":"NINJ1 mediates plasma membrane rupture during lytic cell death","volume":"591","author":"Kayagaki","year":"2021","journal-title":"Nature"},{"key":"B262","first-page":"400","volume-title":"The Puzzle People: Memoirs of a Transplant Surgeon","author":"Starzl","year":"2003"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2025.1575703\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:52:35Z","timestamp":1745499155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2025.1575703\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":262,"alternative-id":["10.3389\/frtra.2025.1575703"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2025.1575703","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1575703"}}